Skip to content
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: October 21, 2024

Leil Storage: Green File Storage for Africa

October 21, 2024

Leil Storage for Africa Leil Storage announces the expansion of its Green Storage Initiative, an endeavor set to revolutionize file storage across Africa. This initiative,

Read More

Leil Storage: Green File Storage for Africa

October 21, 2024

Leil Storage for Africa Leil Storage announces the expansion of its Green Storage Initiative, an endeavor set to revolutionize file storage across Africa. This initiative,

Read More

Transforming Finance Through Scalable Infrastructure: Join the Digital Finance Breakfast in Sandton

October 21, 2024

JOHANNESBURG, Oct. 21, 2024 (GLOBE NEWSWIRE) — IT News Africa, in partnership with OADC, is excited to announce an exclusive Digital Finance Breakfast on 29 October 2024 at the Radisson Blu, Sandton. This

Read More

Transforming Finance Through Scalable Infrastructure: Join the Digital Finance Breakfast in Sandton

October 21, 2024

JOHANNESBURG, Oct. 21, 2024 (GLOBE NEWSWIRE) — IT News Africa, in partnership with OADC, is excited to announce an exclusive Digital Finance Breakfast on 29 October 2024 at the Radisson Blu, Sandton. This

Read More

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

October 21, 2024

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad

Read More

Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

October 21, 2024

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad

Read More
Page1 Page2 Page3 … Page12
RECENT POSTS

2026 World Cup Leaves Mark with Record Attendance and Controversies

July 20, 2026

2026 World Cup Leaves Mark with Record Attendance and Controversies

July 20, 2026

DRC’s Neighbors Bolster Ebola Preparedness Amid Rising Cases

July 20, 2026

DRC’s Neighbors Strengthen Ebola Preparedness Amidst Rising Cases

July 20, 2026

DRC’s Neighbors Strengthen Ebola Preparedness Amidst Rising Cases

July 20, 2026

2026 World Cup: The Tournament That Changed Football Forever

July 20, 2026

2026 World Cup: The Tournament That Changed Football Forever

July 20, 2026

African Development Bank Group Allocates $13 Million for Ebola Outbreak Response in Central Africa

July 20, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.